IV 
109TH CONGRESS 
1ST SESSION 
H. CON. RES. 122 
Expressing the sense of Congress regarding the need for further study of 
the neurological disorder dystonia. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 5, 2005 
Mr. DAVIS of Illinois submitted the following concurrent resolution; which was 
referred to the Committee on Energy and Commerce 
CONCURRENT RESOLUTION 
Expressing the sense of Congress regarding the need for 
further study of the neurological disorder dystonia. 
Whereas dystonia is a neurological disorder characterized by 
powerful and painful involuntary muscle spasms that 
cause twisting, repetitive muscle movements, and sus-
tained postural deformities; 
Whereas dystonia can affect many muscle groups simulta-
neously; 
Whereas several forms of dystonia are genetically inherited, 
while other forms are considered secondary dystonia due 
to birth injury, physical trauma, exposure to certain 
medications, surgery, or stroke; 
Whereas there is no known cure for dystonia and though 
treatments are available, current medical therapies only
•HCON 122 IH 
superficially address symptoms without curing the actual 
disease; 
Whereas individuals of all ages, genders, and ethnic back-
grounds are affected by dystonia; 
Whereas dystonia is the third most common movement dis-
order and affects many more people than better known 
disorders such as Huntington’s disease, muscular dys-
trophy, and Lou Gehrig’s disease (amyotrophic lateral 
sclerosis); 
Whereas dystonia affects an estimated 300,000 people in 
North America; 
Whereas many individuals who suffer from dystonia are alien-
ated from their communities and the workplace, causing 
such individuals to experience isolation and psychological 
distress and creating the need for greater public aware-
ness, understanding, and tolerance; and 
Whereas the National Institutes of Health recently issued a 
program announcement entitled ‘‘Studies Into the Causes 
and Mechanisms of Dystonia’’ to support the study of 
dystonia: Now, therefore, be it 
Resolved by the House of Representatives (the Senate 
concurring), That it is the sense of Congress that— 
(1) the Director of the National Institutes of 
Health (NIH) should take a leadership role in the 
fight against dystonia by— 
(A) continuing the current collaboration 
between the National Institute of Neurological 
Disorders and Stroke (NINDS), the National 
Institute on Deafness and Other Communica-
•HCON 122 IH 
tion Disorders (NIDCD), and the National Eye 
Institute with respect to dystonia; 
(B) encouraging NINDS and NIDCD to 
provide the necessary funding for intramural 
and extramural biomedical research and edu-
cation with respect to dystonia through the co-
sponsorship of workshops and seminars with re-
spected patient organizations; and 
(C) by exploring collaborative opportunities 
for dystonia research at the John Edward Por-
ter Neuroscience Research Center at the Na-
tional Institutes of Health and pursuing more 
aggressive programs in dystonia research using 
the multidisciplinary approach of the Center; 
(2) funding should be increased for basic bio-
medical research for dystonia as well as other neuro-
logical disorders through the National Institutes of 
Health; 
(3) further research is needed to identify an ac-
curate diagnostic test for dystonia and an epidemio-
logical study should be conducted to determine the 
frequency of the disease in the population; 
(4) patient access to safe and effective dystonia 
therapies such as botulinum toxin injections should 
be improved; and
•HCON 122 IH 
(5) public awareness and professional education 
regarding dystonia needs to increase through part-
nerships between the Federal Government and pa-
tient advocacy organizations. 
Æ